Fluent.ai Launches Partnership with BSH to Voice Automate the Assembly Line, Increasing Efficiency and Improving Factory Worker Ergonomics
The company’s patented speech-to-intent AI technology, currently deployed in one of BSH’s German factories, reduces transition time on the assembly line for up to 75 – 100% efficiency gains
MONTREAL, June 10, 2021 (GLOBE NEWSWIRE) -- Fluent.ai, a Canadian embedded voice recognition solutions company, today announced the launch of its partnership with BSH, Europe’s leading manufacturer of connected home appliances, to bring voice automation to its factories. The company came to Fluent.ai through its Venture Client unit, BSH Startup Kitchen, with the goal of increasing efficiency and improving ergonomics for factory operators on the assembly line.
“After considering 11 companies for this partnership, we chose Fluent.ai because of their key competitive differentiators,” said Ion Hauer, Venture Partner at BSH Startup Kitchen. “Fluent.ai’s offline technology is noise robust and low latency which is critical – their solution is able to quickly and accurately understand voice commands even in the noisy environment of the factory. They also provide multilingual and multi-accent support which is key for BSH’s global reach.”
Currently, factory operators must press physical buttons at their workstations in order to move appliances along the assembly line, which takes up to four seconds per workplace. With this in mind, BSH was in search of a solution that would increase efficiency and improve ergonomics for their workers.
Fluent.ai developed a voice control solution for workers to operate heavy machinery by speaking into a headset connected to an embedded voice recognition system. The factory operator simply speaks a WakeWord followed by a command to trigger the appropriate movement of the appliance on the assembly line. The solution also offers improved ergonomics, as workers are able to conveniently operate the assembly line hands-free. Early results from the partnership show major improvements to factory worker productivity, with BSH seeing potential for 75-100 percent efficiency gains on the line.
“Implementing Fluent’s technology has already improved efficiencies within our factory, with initial implementation of the solution cutting down the transition time from four seconds to one and a half,” said Markus Maier, the project lead in BSH’s Traunreut factory. “In the long run, the production time savings will be invaluable. We started with Fluent.ai on one factory assembly line, moved to three, and BSH is considering rolling the technology out worldwide.”
BSH is known for innovation and fostering collaboration between startups and corporate companies. The company has a variety of appliance brands in its portfolio including Bosch, Siemens, Gaggenau, NEFF, Thermador and many more. “We are thrilled to be working with BSH, a company at the forefront of innovation that truly makes startup-corporate collaboration work. Seeing your solution out in the real world is incredibly rewarding, and we look forward to continuing and growing our collaboration with BSH”, says Fluent.ai CEO, Probal Lala, of the partnership.
To learn more about Fluent.ai, visit https://fluent.ai/.
Fluent.ai Inc. is a Canadian speech recognition software company founded in 2015. Fluent.ai’s mission is to voice-enable the world’s devices, allowing everyone be understood by their technology. Through over seven years of research, the company developed a range of artificial intelligence (AI) voice interface software products to offer up to original equipment manufacturers (OEMs) and service providers. Fluent.ai’s solutions deliver unprecedented accuracy along with a highly customizable user experience with the goal of finally breaking the barriers to global adoption of voice user interfaces.
BSH Hausgeräte GmbH, with a total turnover of some EUR 13.9 billion and 60,000 employees in 2020, is a global leader in the home appliance industry. The company’s brand portfolio includes eleven well-known appliance brands like Bosch, Siemens, Gaggenau and Neff as well as the
ecosystem brand Home Connect and service brands like Kitchen Stories. BSH produces at around 38 factories and is represented in some 50 countries.
BSH is a Bosch Group company.
Media Contact for Fluent.ai:
To view this piece of content from ml.globenewswire.com, please give your consent at the top of this page.
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire
Subscribe to all the latest releases from GlobeNewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire
Karolinska Development’s portfolio company Modus Therapeutics and Imperial College London to conduct clinical study of sevuparin in severe malaria15.6.2021 11:24:44 CEST | Press release
STOCKHOLM, SWEDEN – June 15, 2021. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces today that its portfolio company Modus Therapeutics has entered into a collaboration agreement with Imperial College London to evaluate the effect of its drug candidate sevuparin in patients with severe malaria. Sevuparin is currently being developed in the indication sepsis/septic shock, a condition that bears resemblance to the systemic inflammatory reaction that occurs in connection with severe malaria infection. Malaria causes more than 400,000 deaths per year and the need for new and effective drugs is therefore great. Severe malaria continues to be a medical challenge in several parts of the world. The disease often affects children and the need for effective drugs is great as malaria can induce a systemic inflammatory reaction leading to multi-organ failure, a reaction similar to that seen in sepsis/septic shock. The purpose of the collaboration announced today is to conduct a clinica
Karolinska Developments portföljbolag Modus Therapeutics och Imperial College London planerar klinisk studie av sevuparin mot svår malaria15.6.2021 11:24:44 CEST | Pressemelding
STOCKHOLM, SVERIGE 15 juni 2021. Karolinska Development AB (Nasdaq Stockholm: KDEV) meddelar idag att portföljbolaget Modus Therapeutics och Imperial College London har ingått ett samarbetsavtal i syfte att utvärdera effekten av bolagets läkemedelskandidat sevuparin i patienter med svår malaria. Sevuparin utvecklas sedan tidigare inom indikationen sepsis/septisk chock, ett tillstånd som bär vissa likheter med den systemiska inflammationsreaktion som uppstår i samband med svår malariainfektion. Malaria orsakar fler än 400 000 dödsfall per år och behovet av nya och effektiva läkemedel är därför stort. Svår malaria utgör fortsatt en medicinsk utmaning i flera delar av världen. Sjukdomen drabbar ofta barn och behovet av effektiva läkemedel är stort eftersom malaria kan inducera en systemisk inflammatorisk reaktion som leder till multiorgansvikt, en reaktion som liknar den man ser vid sepsis/septisk chock. Syftet med det samarbete som annonseras idag är att genomföra en klinisk studie för a
RESULT OF RIKSBANK CERTIFICATE SALE15.6.2021 10:15:00 CEST | Press release
AuctionAuction resultsAuction date2021-06-15Start date2021-06-16Maturity date2021-06-23Interest rate, %0.00Offered volume, SEK bn484.0Total bid amount, SEK bn2362.7Accepted volume, SEK bn484.0Number of bids17Percentage alloted, %20.485
CONDITIONS FOR SALE OF RIKSBANK CERTIFICATES15.6.2021 09:30:00 CEST | Press release
Bid date, 2021-06-15Auction date2021-06-15Settlement date2021-06-16Maturity Date2021-06-23Nominal amount484 billion SEKInterest rate, %0.00Bid times09.30-10.00 (CET/CEST) on the Bid dateConfirmation of bids to email@example.comThe lowest accepted bid volume1 million SEKThe highest accepted bid volume484 billion SEKAllocation Time10.15 (CET/CEST) on the Bid dateProjected minimum liquidity surplus during the term968 billion SEKExpected excess liquidity at full allotment484 billion SEK Stockholm, 2021-06-15
Klövern kommer att sammankalla en extra bolagsstämma enligt begäran från Corem15.6.2021 09:06:03 CEST | Pressemelding
En extra bolagsstämma kommer att hållas i Klövern AB (publ) (”Klövern”) den 9 juli 2021 för val av ny styrelse i enlighet med begäran från Corem. Kallelse utfärdas separat. Corem Property Group AB (publ) (”Corem”) lämnade den 29 mars 2021 ett offentligt uppköpserbjudande till aktieägarna i Klövern. Corem förklarade idag erbjudandet ovillkorat och förlängde acceptfristen till den 23 juni 2021. Corem kontrollerar cirka 89,1 procent av de utestående aktierna och cirka 90,8 procent av rösterna i Klövern. Klövern AB (publ) För ytterligare information, vänligen kontakta: Pia Gideon, styrelseordförande i Klövern Tel: 070-546 71 00 Klövern är ett fastighetsbolag som med närhet och engagemang erbjuder attraktiva lokaler i tillväxtregioner. Klövern är noterat på Nasdaq Stockholm. Ytterligare information finns på www.klovern.se. Klövern AB (publ), Bredgränd 4, 111 30 Stockholm. Tel: 010-482 70 00, Email: firstname.lastname@example.org. Detta pressmeddelande har offentliggjorts på svenska och engelska. Vid en ev
Klövern will convene an Extraordinary General Meeting in accordance with a request from Corem15.6.2021 09:06:03 CEST | Press release
An Extraordinary General Meeting will be held in Klövern AB (publ) (”Klövern”) on 9 July 2021 to elect a new Board of Directors in accordance with a request from Corem. A notice will be issued separately. On 29 March 2021, Corem Property Group AB (publ) (”Corem”) announced a public offer to the shareholders of Klövern. Today, Corem declared the offer unconditional and extended the acceptance period to 23 June 2021. Corem controls approximately 89.1 percent of the outstanding shares and approximately 90.8 percent of the votes in Klövern. Klövern AB (publ) For further information, pleasecontact: Pia Gideon, Chairman of the Board of Directors in Klövern Phone: +46 70 546 71 00 Klövern is a real estate company committed to working closely with customers to offer them attractive premises in growth regions. Klövern is listed on Nasdaq Stockholm. For further information, see www.klovern.se. Klövern AB (publ), Bredgränd 4, 111 30 Stockholm. Phone: +46 10 482 70 00. Email: email@example.com. This
Ahold Delhaize share buyback update15.6.2021 08:00:00 CEST | Press release
Zaandam, the Netherlands, June 15, 2021 – Ahold Delhaize has repurchased 254,009 of Ahold Delhaize common shares in the period from June 7, 2021 up to and including June 11, 2021. The shares were repurchased at an average price of € 24.58 per share for a total consideration of € 6.2 million. These repurchases were made as part of the €1 billion share buyback program announced on November 4, 2020. The total number of shares repurchased under this program to date is 20,396,452 common shares for a total consideration of € 470.8 million. Download the share buyback transactions excel sheet for detailed individual transaction information from https://www.aholddelhaize.com/en/investors/share-buyback-programs/2021/ This press release is issued in connection with the disclosure and reporting obligation set out in Article 2(2) of the EU Regulation that contains technical standards for buyback programs